NEW YORK, June 22, 2012 /PRNewswire/ -- When weighing prostate cancer treatment options, potential side effects such as urinary control and sexual potency are the hot buttons. Seldom discussed, though significantly more damaging, is bone disease. Early diagnosis of prostate cancer, and the right treatment path, can drastically reduce a man's risk of developing prostate cancer-related bone disease.
As reported in the Bone Health In Focus Prostate Cancer report, which aims to increase awareness of prostate cancer-related bone disease, only one third of prostate cancer patients claim to have discussed bone health and the risk of bone metastases with their physician. Shocking for a secondary disease that can significantly impair quality of life and ultimately decrease survival by more than three years.
Prostate cancer-related bone disease results from either:
1) Cancer Treatment-Induced Bone Loss (CTIBL)
"Seldom are men made aware of the damaging affects of androgen deprivation therapy (ADT) on their bones," says Dr. Samadi. "Hormone therapy for prostate cancer is proven to significantly decrease bone mass and cause bone weakening."
Also in the Bone Health In Focus P